Molecular diagnostics for existing and emerging infections - Complementary tools for a new era of clinical microbiology

被引:0
|
作者
Dumler, JS [1 ]
Valsamakis, A [1 ]
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Div Med Microbiol, Baltimore, MD 21205 USA
关键词
bacterial toxins; Ehrlichia species; enterovirus; hepatitis C virus; molecular diagnostics; PCR; uncultured pathogens; viral load;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Diagnostic molecular methods have had a large effect on diagnosis and management of infectious diseases. These tools have been developed in response to diagnostic methods that lack sensitivity, specificity, or rapid turnaround time, to assist with identification of agents that are difficult to cultivate or classify or as methods for assessing the effects of antiviral or antimicrobial agents in chronic infection. Molecular methods have also enabled microbiologists to define disease by the presence of virulence, toxin, or antimicrobial resistance genes and to identify potentially important clones of organisms responsible for outbreaks of infection. Early outcome-based studies suggest that molecular methods may provide substantial reductions in per patient costs. Nucleic acid diagnostic methods will continue to be used in infectious disease and microbiology, and increasingly appear to be complementary tools with import diagnostic patient management, and health care cost benefits for the laboratory and health care systems.
引用
下载
收藏
页码:S33 / S39
页数:7
相关论文
共 50 条
  • [31] Molecular Cytopathology A New Era of Clinical Cytology
    Osamura, Robert Y.
    ACTA CYTOLOGICA, 2009, 53 (03) : 245 - 246
  • [32] Welcome to a new era for Clinical and Molecular Allergy
    Enrico Maggi
    Clinical and Molecular Allergy, 13 (1)
  • [33] MOLECULAR GENETIC DIAGNOSTICS AND ASD: RELEVANCE FOR CLINICAL PRACTICE IN THE ERA OF PRECISION MEDICINE
    Muhle, Rebecca
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S139 - S139
  • [34] Diagnosis of Yersinia enterocolitica Infection in Cancer Patients With Diarrhea in the Era of Molecular Diagnostics for Gastrointestinal Infections
    Wang, Elizabeth Wenqian
    Bhatti, Micah
    Cantu, Sherry
    Okhuysen, Pablo C.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
  • [35] New tools for rapid clinical and bioagent diagnostics: microwaves and plasmonic nanostructures
    Aslan, Kadir
    Geddes, Chris D.
    ANALYST, 2008, 133 (11) : 1469 - 1480
  • [36] Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools
    Selva-O'Callaghan, Albert
    Trallero-Araguas, Ernesto
    Angeles Martinez, Maria
    Labrador-Horrillo, Moises
    Pinal-Fernandez, Iago
    Maria Grau-Junyent, Josep
    Juarez, Candido
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (06) : 737 - 747
  • [37] WGS Analysis and Interpretation in Clinical and Public Health Microbiology Laboratories: What Are the Requirements and How Do Existing Tools Compare?
    Wyres, Kelly L.
    Conway, Thomas C.
    Garg, Saurabh
    Queiroz, Carlos
    Reumann, Matthias
    Holt, Kathryn
    Rusu, Laura I.
    PATHOGENS, 2014, 3 (02) : 437 - 458
  • [38] The clinical microbiology laboratory and infection control: Emerging pathogens, antimicrobial resistance, and new technology
    Pfaller, MA
    Herwaldt, LA
    CLINICAL INFECTIOUS DISEASES, 1997, 25 (04) : 858 - 870
  • [39] Cell-free DNA and RNA in plasma as new tools for molecular diagnostics
    Wong, BCK
    Lo, YMD
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (06) : 785 - 797
  • [40] Regulatory variations in the era of next-generation sequencing: Implications for clinical molecular diagnostics
    Jarinova, Olga
    Ekker, Marc
    HUMAN MUTATION, 2012, 33 (07) : 1021 - 1030